Plasma levels of soluble E-selectin were significantly higher in PAD stage II patients compared to healthy age- and sex-matched individuals without PAD diagnosis and no cardiovascular risk factors (p = 0.0012), but did not differ compared to those with cardiovascular risk factors (Figure 2A). This evidence concerns the gene SELE and peripheral arterial disease.